JPMorgan lowered the firm’s price target on Option Care Health (OPCH) to $33 from $40 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health price target lowered to $23 from $37 at TD Cowen
- Option Care Health price target lowered to $30 from $40 at Stephens
- Option Care Health downgraded to Neutral from Buy at BofA
- Option Care Health price target lowered to $39 from $45 at UBS
- Option Care Health price target lowered to $32 from $42 at Barrington